DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Melarsoprol
Melarsoprol
Trs
Human African Trypanosomiasis in Non-Endemic Countries (2000-2010)
Nifurtimox-Eflornithine Combination Therapy for Second-Stage
Drug-N-Therapeutics-Committee.Pdf
World Health Organization Model List of Essential Medicines, 21St List, 2019
Pharmacological Approaches to Antitrypanosomal Chemotherapy
Efficacy and Toxicity of Fexinidazole and Nifurtimox Plus Eflornithine in the Treatment of African Trypanosomiasis: a Systematic Review
The Drugs of Sleeping Sickness: Their Mechanisms of Action and Resistance, and a Brief History
Update on Field Use of the Available Drugs for the Chemotherapy Of
Positively Selected Modifications in the Pore of Tbaqp2 Allow Pentamidine
Application for Inclusion of Fexinidazole in the Who Model List of Essential Medicines (Adult & Children)
Toxicity of a Combination of Nifurtimox-Melarsoprol in Northern
Aquaglyceroporin 2 Controls Susceptibility to Melarsoprol and Pentamidine in African Trypanosomes
Final1-Aritmo-Final-Report-V2-0Final.Pdf
Common Study Protocol for Observational Database Studies WP5 – Analytic Database Studies
Assessment Report
The Selection and Use of Essential Medicines
Drugs for Parasitic Infections (2013 Edition)
Top View
Chemogenomic Profiling of Anti-Leishmanial Efficacy and Resistance in The
Amebic Meningoencephalitis.Qxd
TITLE PAGE the Distribution of Nifurtimox Across the Healthy And
ATC-Index Mit DDD-Angaben Für Den Deutschen Arzneimittelmarkt Berlin 2013, 12
Human African Trypanosomiasis, Chagas Disease and Leishmaniases
Effects of Trypanocidal Drugs on DNA Synthesis: New Insights Into Melarsoprol Growth Inhibition Cambridge.Org/Par
Microorganisms-08-00950-V3.Pdf
Vitro Drug Susceptibility of Two Strains of the Wildlife Trypanosome, Trypanosoma Copemani: a Comparison with Trypanosoma Cruzi
The Medical Letter
Inhibitory Activity of Marine Sponge-Derived Natural Products Against Parasitic Protozoa
Melarsoprol Versus Eflornithine for Treating Late-Stage Gambian Trypanosomiasis in the Republic of the Congo
WHO Model List of Essential Medicines for Children
WHO Interim Guidelines for the Treatment of Gambiense Human African Trypanosomiasis
Overview of the Evidence for Safety and Efficacy of Medicines for the Treatment of Neglected Tropical Diseases in Children
Reviewer 2: NIFURTIMOX+EFLORNITHINE(N+E)
Coupled Enzyme Activity and Thermal Shift Screening of the Maybridge
Improved Melarsoprol Therapy for Trypanosoma Brucei Rhodesiense Sleeping Sickness
The Selection and Use of Essential Medicines
Facts & Figures
Clinical Study on the Melarsoprol-Related Encephalopathic Syndrome: Risk Factors and HLA Association
UKPMC Funders Group Author Manuscript Nature
Kinetoplastida: New Therapeutic Strategies Croft S.L.*
Sleeping Sickness) the Road to Elimination Revisited—Achievements and Remaining Challenges
The Need for New Antiparasitic Agents
The Selection and Use of Essential Medicines